tanzania
Medicines for Malaria Venture
The Swiss Malaria Group members are operating in almost all malaria endemic countries. With their commitment they are contributing to the global fight against malaria. For more information on our members, please go to the member's website by clicking on the member's logo.
Project 2
Supporting development of a key easy-to-administer and long-protective antimalarial - dihydroartemisinin-piperaquine (Euroartesim).
SolidarMed
The Swiss Malaria Group members are operating in almost all malaria endemic countries. With their commitment they are contributing to the global fight against malaria. For more information on our members, please go to the member's website by clicking on the member's logo.
Project 1
Primary health care in 3 districts in rural Tanzania: improving access to early diagnosis and treatment, sensitization / IEC.
Swiss Agency for Development and Cooperation (SDC)
The Swiss Malaria Group members are operating in almost all malaria endemic countries. With their commitment they are contributing to the global fight against malaria. For more information on our members, please go to the member's website by clicking on the member's logo.
Project 2
Netcell strengthening malaria control in Tanzania
- reduce illness and deaths caused by malaria by supporting National Malaria Control Program (NMCP) within the Ministry of Health
- technical assistance to the National Malaria Control provided by Swiss TPH
- contribution to reducing childhood mortality by 63% over the past two decades.
Countries
Impact
Population covered: 5.3 million (11% of Tanzanian population); Malaria deaths reduced by 50% between 2005-2016; 87 million nets distributed, saving approx. 60,000 lives of children < 5 years
Duration
NMCP support since 2002, current contribution 2013-2019 (6.25 million)
Activity
Vector control
Swiss Tropical and Public Health Institute
The Swiss Malaria Group members are operating in almost all malaria endemic countries. With their commitment they are contributing to the global fight against malaria. For more information on our members, please go to the member's website by clicking on the member's logo.
Project 2
RTS,S: most advanced candidate for a malaria vaccine. Swiss TPH helped coordinate a large-scale clinical trail involving more than 16,000 children. Swiss TPH also calculated the long-term impact and cost-effectiveness of RTS,S in 43 African countries.
Countries
burkina-faso gabon ghana kenya malawi mozambique tanzania
Impact
16,000 children
Duration
2009 - 2014
Activity
Innovation & Research
Syngenta
The Swiss Malaria Group members are operating in almost all malaria endemic countries. With their commitment they are contributing to the global fight against malaria. For more information on our members, please go to the member's website by clicking on the member's logo.
Project 1
Launch of ACTELLIC 300CS for IRS & following establishment of NgenIRS project. The project's aim is to make the most effective, long lasting insecticides available to malaria control programmes to support insecticide resistance management strategies.
Countries
benin burkina-faso ethiopia ghana kenya madagascar mali malawi mozambique rwanda tanzania uganda zambia zimbabwe
Impact
6.7 million units of ACTELLIC procured
Duration
2013/2016 - ongoing
Activity
Vector control
Unisanté
The Swiss Malaria Group members are operating in almost all malaria endemic countries. With their commitment they are contributing to the global fight against malaria. For more information on our members, please go to the member's website by clicking on the member's logo.
Project 1
Usefulness of antimalarial drug concentrations in blood as a monitoring tool for evaluating population drug usage in relation to diagnosis and treatment environment.
Project 2
Residual antimicrobial drug concentrations in blood as a monitoring tool for evaluating population medicine usage and the impact of stewardship interventions on drug pressure.